Eric Beyssac

2.2k total citations
73 papers, 1.8k citations indexed

About

Eric Beyssac is a scholar working on Pharmaceutical Science, Food Science and Molecular Biology. According to data from OpenAlex, Eric Beyssac has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmaceutical Science, 22 papers in Food Science and 10 papers in Molecular Biology. Recurrent topics in Eric Beyssac's work include Drug Solubulity and Delivery Systems (24 papers), Advanced Drug Delivery Systems (18 papers) and Proteins in Food Systems (17 papers). Eric Beyssac is often cited by papers focused on Drug Solubulity and Delivery Systems (24 papers), Advanced Drug Delivery Systems (18 papers) and Proteins in Food Systems (17 papers). Eric Beyssac collaborates with scholars based in France, Canada and United States. Eric Beyssac's co-authors include Ghislain Garrait, Muriel Subirade, Monique Alric, Jean‐Michel Cardot, Valérie Hoffart, S. Blanquet, Jean-Marc Aiache, Gabriel Remondetto, Sylvain Denis and Pedro A. Alvarez and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Agricultural and Food Chemistry and Food Chemistry.

In The Last Decade

Eric Beyssac

71 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Beyssac France 28 669 658 360 245 162 73 1.8k
James W. Ayres United States 25 467 0.7× 591 0.9× 450 1.3× 203 0.8× 118 0.7× 91 1.9k
Charles M. Heard United Kingdom 28 301 0.4× 756 1.1× 322 0.9× 207 0.8× 77 0.5× 101 2.1k
Yellela S.R. Krishnaiah India 28 629 0.9× 1.6k 2.4× 233 0.6× 132 0.5× 96 0.6× 77 2.5k
Nattha Kaewnopparat Thailand 13 260 0.4× 405 0.6× 192 0.5× 134 0.5× 210 1.3× 30 963
Bimlesh Kumar India 26 351 0.5× 551 0.8× 326 0.9× 100 0.4× 74 0.5× 133 1.8k
Yusrida Darwis Malaysia 21 307 0.5× 834 1.3× 426 1.2× 70 0.3× 95 0.6× 51 2.0k
Vivek S. Dave United States 17 211 0.3× 623 0.9× 281 0.8× 77 0.3× 172 1.1× 29 1.4k
N.P. Aditya India 22 826 1.2× 719 1.1× 532 1.5× 135 0.6× 235 1.5× 35 2.2k
Mario Jug Croatia 24 290 0.4× 694 1.1× 208 0.6× 54 0.2× 256 1.6× 58 1.5k
Nádia Araci Bou‐Chacra Brazil 26 400 0.6× 848 1.3× 386 1.1× 45 0.2× 266 1.6× 105 2.1k

Countries citing papers authored by Eric Beyssac

Since Specialization
Citations

This map shows the geographic impact of Eric Beyssac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Beyssac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Beyssac more than expected).

Fields of papers citing papers by Eric Beyssac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Beyssac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Beyssac. The network helps show where Eric Beyssac may publish in the future.

Co-authorship network of co-authors of Eric Beyssac

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Beyssac. A scholar is included among the top collaborators of Eric Beyssac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Beyssac. Eric Beyssac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basle, Yoann Le, et al.. (2024). Development and characterization of novel fast-dissolving pentobarbital suppositories for pediatric procedural sedation and comparison with lipophilic formulations. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114532–114532.
4.
Martin, Baptiste, Ghislain Garrait, Eric Beyssac, et al.. (2020). Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds. Pharmaceutical Research. 37(6). 92–92. 10 indexed citations
5.
Solís-Cruz, Bruno, Daniel Hernández‐Patlan, Juan D. Latorre, et al.. (2019). Evaluation of Cellulosic Polymers and Curcumin to Reduce Aflatoxin B1 Toxic Effects on Performance, Biochemical, and Immunological Parameters of Broiler Chickens. Toxins. 11(2). 121–121. 43 indexed citations
7.
Fliss, Ismaı̈l, et al.. (2017). Molecular and biopharmaceutical investigation of alginate–inulin synbiotic coencapsulation of probiotic to target the colon. Journal of Microencapsulation. 34(2). 171–184. 34 indexed citations
8.
Gomaa, Ahmed, et al.. (2016). A prebiotic matrix for encapsulation of probiotics: physicochemical and microbiological study. Journal of Microencapsulation. 33(1). 89–101. 48 indexed citations
9.
Garrait, Ghislain, et al.. (2014). Improved bioavailability of vitamin D3 using a β-lactoglobulin-based coagulum. Food Chemistry. 172. 361–367. 38 indexed citations
10.
Hoffart, Valérie, et al.. (2012). Development and characterization of coated-microparticles based on whey protein/alginate using the Encapsulator device. Drug Development and Industrial Pharmacy. 39(1). 128–137. 23 indexed citations
11.
Laine, E, Valérie Hoffart, Ghislain Garrait, et al.. (2012). Efficacy of Mucoadhesive Hydrogel Microparticles of Whey Protein and Alginate for Oral Insulin Delivery. Pharmaceutical Research. 30(3). 721–734. 62 indexed citations
12.
Hoffart, Valérie, et al.. (2010). Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast. Journal of Microencapsulation. 27(4). 292–302. 77 indexed citations
13.
Hoffart, Valérie, et al.. (2009). Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment. Drug Development and Industrial Pharmacy. 35(9). 1103–1112. 23 indexed citations
14.
Blanquet, S., et al.. (2006). Use of whey protein beads as a new carrier system for recombinant yeasts in human digestive tract. Journal of Biotechnology. 127(1). 151–160. 28 indexed citations
15.
Fagiolino, Pietro, et al.. (2001). Preliminary study of the theophylline chronopharmacokinetics by salivary assay. Journal de Pharmacie Clinique. 16(1). 1 indexed citations
16.
Galmier, Marie‐Josèphe, et al.. (2000). High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor. Biomedical Chromatography. 14(3). 202–204. 22 indexed citations
17.
Galmier, Marie‐Josèphe, Eric Beyssac, J. Petit, Jean-Marc Aiache, & Claire Lartigue. (1999). Validation of a reversed-phase liquid chromatographic method for the determination of hydrocortisone phosphate disodium in a gel formulation. Journal of Pharmaceutical and Biomedical Analysis. 20(1-2). 405–409. 11 indexed citations
18.
Beyssac, Eric, et al.. (1993). In vitro/in vivo correlations: Scientific implications and standardisation. European Journal of Drug Metabolism and Pharmacokinetics. 18(1). 113–120. 36 indexed citations
19.
Beyssac, Eric, et al.. (1991). Comparison of continuous, constant rate enteral tube feeding in supine patients to bolus food intake in ambulatory, healthy subjects regarding bioavailability of perorally administered cefroxadine.. PubMed. 13(9). 637–42. 2 indexed citations
20.
Beyssac, Eric, et al.. (1991). A New Method of Dissolution In Vitro, the “Bio-Dis” Apparatus: Comparison with the Rotating Bottle Method and In Vitro:ln Vivo Correlations. Journal of Pharmaceutical Sciences. 80(10). 991–994. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026